Suppr超能文献

鉴定非经典人类白细胞抗原分子(MICA)作为与肾移植不可逆排斥相关的体液免疫靶点。

Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts.

作者信息

Sumitran-Holgersson S, Wilczek H E, Holgersson J, Söderström K

机构信息

Division of Clinical Immunology, Transplantation Surgery, and Microbiology and Tumor Biology Center, Karolinska Institutet, Huddinge University Hospital AB, Stockholm, Sweden.

出版信息

Transplantation. 2002 Jul 27;74(2):268-77. doi: 10.1097/00007890-200207270-00019.

Abstract

BACKGROUND

A substantial portion of kidney allografted patients experience early acute rejection episodes and even irreversible rejections in the early posttransplantation period. The presence of HLA alloantibodies before grafting is associated with early immunological complications, but in many patients rejections and graft loss occur even in the absence of such antibodies.

METHODS

In this study, 748 serum samples taken before and at various time points after kidney transplantation from 139 patients were investigated for the presence, frequency, and specificity of kidney microvascular endothelial cell (KMEC)-reactive antibodies using major histocompatability class (MHC) I-related chain A (MICA) transfected cells and flow cytometry, antibody blocking experiments, and Western blotting. The ability of MICA-specific antibodies to fix complement and to induce a prothrombotic phenotype in KMECs was investigated.

RESULTS

A polymorphic, 62 kDa nonclassical HLA class I molecule is identified as a new target molecule for reactivity in sera from patients with irreversible rejections. Specific blocking and transfection experiments verified the target molecule as MICA. A significant correlation was established for pre- or posttransplantation MICA humoral immunity and graft loss (P<0.001). MICA-specific antibody titers increased in the posttransplantation period and were present before any signs of clinical rejection. MICA antibody-containing patient sera induced a prothrombotic phenotype in KMECs.

CONCLUSION

The increasing polymorphism detected at the MIC loci combined with the results of this study suggest that typing for the MIC loci and crossmatching for the detection of anti-MIC antibodies before transplantation should be used routinely. A better recipient-donor selection based on a negative crossmatch for both anti-donor HLA and MICA antibodies will decrease early graft rejections and losses.

摘要

背景

相当一部分肾移植患者在移植后的早期会经历急性排斥反应,甚至出现不可逆的排斥反应。移植前存在HLA同种抗体与早期免疫并发症有关,但许多患者即使在没有此类抗体的情况下也会发生排斥反应和移植肾丢失。

方法

在本研究中,使用主要组织相容性复合体(MHC)I类相关链A(MICA)转染细胞、流式细胞术、抗体阻断实验和蛋白质印迹法,对139例患者肾移植前后不同时间点采集的748份血清样本进行检测,以确定肾微血管内皮细胞(KMEC)反应性抗体的存在、频率和特异性。研究了MICA特异性抗体固定补体以及在KMEC中诱导促血栓形成表型的能力。

结果

一种多态性的62 kDa非经典HLA I类分子被确定为不可逆排斥反应患者血清中反应性的新靶分子。特异性阻断和转染实验证实该靶分子为MICA。移植前或移植后MICA体液免疫与移植肾丢失之间存在显著相关性(P<0.001)。MICA特异性抗体滴度在移植后升高,且在任何临床排斥反应迹象出现之前就已存在。含MICA抗体的患者血清在KMEC中诱导促血栓形成表型。

结论

在MIC基因座检测到的多态性增加以及本研究结果表明,移植前应常规进行MIC基因座分型和交叉配型以检测抗MIC抗体。基于抗供体HLA和MICA抗体交叉配型阴性进行更好的受者-供体选择,将减少早期移植肾排斥反应和丢失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验